Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8907071 Toxin peptide therapeutic agents

Patent 8907071 was granted and assigned to Amgen on December, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

89070710

Patent Inventor Names

Colin V. Gegg0

John K. Sullivan0

Joseph G. McGivern0

Kenneth W. Walker0

Leslie P. Miranda0

Shaw-Fen Sylvia Hu0

Stefan I. McDonough0

Hung Q. Nguyen0

Date of Patent

December 9, 2014

Patent Application Number

129382940

Date Filed

November 2, 2010

Patent Citations Received

‌

US Patent 12084518 Trispecific binding proteins and methods of use

‌

US Patent 11872289 Anti-MUC1 antibody-drug conjugate

‌

US Patent 11945882 Method for producing antibody-drug conjugate

‌

US Patent 11976125 B cell maturation antigen binding proteins

Patent Primary Examiner

‌

Anand Desai

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8907071 Toxin peptide therapeutic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API